398 related articles for article (PubMed ID: 27340126)
1. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
2. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
3. CD8
Zhang Y; Qi C; Li L; Hua S; Zheng F; Gong F; Fang M
Inflamm Res; 2019 Jan; 68(1):75-91. PubMed ID: 30430216
[TBL] [Abstract][Full Text] [Related]
4. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
[TBL] [Abstract][Full Text] [Related]
6. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
[TBL] [Abstract][Full Text] [Related]
7. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
[TBL] [Abstract][Full Text] [Related]
8. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
[TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 axis in inflammation and immunopathology.
Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of Roquin aggravates T cell mediated hepatitis in transgenic mice using T cell specific promoter.
Ji YR; Kim HJ; Yu DH; Bae KB; Park SJ; Park SJ; Jang WY; Kang MC; Jeong J; Sung YH; Choi M; Park T; Park T; Yun JW; Lee HS; Lee S; Kim MO; Ryoo ZY
Biochem Biophys Res Commun; 2014 Sep; 452(3):822-7. PubMed ID: 25201726
[TBL] [Abstract][Full Text] [Related]
12. IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Popovic B; Golemac M; Podlech J; Zeleznjak J; Bilic-Zulle L; Lukic ML; Cicin-Sain L; Reddehase MJ; Sparwasser T; Krmpotic A; Jonjic S
PLoS Pathog; 2017 Apr; 13(4):e1006345. PubMed ID: 28448566
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.
Erhardt A; Wegscheid C; Claass B; Carambia A; Herkel J; Mittrücker HW; Panzer U; Tiegs G
J Immunol; 2011 May; 186(9):5284-93. PubMed ID: 21441449
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
15. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
Sun R; Tian Z; Kulkarni S; Gao B
J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
[TBL] [Abstract][Full Text] [Related]
18. IL-33/ST2 Axis Plays a Protective Effect in
Kuo CF; Chen WY; Yu HH; Tsai YH; Chang YC; Chang CP; Tsao N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638904
[TBL] [Abstract][Full Text] [Related]
19. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
20. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.
Erhardt A; Biburger M; Papadopoulos T; Tiegs G
Hepatology; 2007 Feb; 45(2):475-85. PubMed ID: 17256743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
